Biological Building Blocks Made Easy
Biological Building Blocks Made Easy
Long plasmid build times delay the engineering cycle and slow discovery.
In-house plasmid builds are not scalable and consume skilled scientists’ time, diverting focus from high-value research.
Geopolitical uncertainty and IP risks with offshore manufacturers hinder reliability and security.
WayBio partners with research teams to cut the time from experimental concept to ready‑to‑test construct, accelerating discovery and development.
WayBio specializes in de novo synthesis of complex genes and plasmids, subcloning, and creating single and combinatorial variants on existing plasmids with precision and efficiency.
Waybio provides trade-proof operations and ironclad US data security. All work and data stay 100% onshore, no disruptions from geopolitical shifts.
Local experts
for challenging
plasmid projects
